Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 15 Life Science Startup Investors in Singapore

Last updated: Apr 2024 A list of 15 angel investors and VC funds that invest in Life science startups based in Singapore. We rank investors based on the number of investments they made in Life science companies from Singapore. We update this investor list every month.

Top 15 Life Science Startup Investors in Singapore

Investor	Life Science Singapore investments
EDBI	3
Anzu Partners	3
Eisai	2
SK Securities	1
M Capital Partners	1
Temasek Holdings	1
Altara Ventures	1
Hana Financial Investment	1
Openspace	1
Seeds Capital	1
KT investment	1
K3 Ventures	1
Amgen Ventures	1
Nestlé	1
Lightstone Ventures	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

EDBI invests in high growth technology sectors. EDBI Creates value and empowers companies to build sustainable legacies.

Investment focus

Biotechnology, Software, Health Care
Series C, Series B, Series D
United States, Singapore, China

Portfolio highlights

LXA — LXA operates as a fintech company, that focus on reimagining of Asia's mortgage ecosystem.
Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with ArteraAI. Transforming cancer therapy through innovation.
Engine Biosciences — We digitize and decipher complex biology with cutting-edge technologies to discover and develop life-changing medicines.

Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.

Investment focus

Biotechnology, Manufacturing, Software
Series A, Series B, Funding Round
United States, Canada, Spain

Portfolio highlights

Aspinity — Aspinity offers neuromorphic all-analog integrated circuit technology that can replicate the functionality of digital signal processors. It reduces the system power requirements for always-on sensing applications.Their vision is that battery life does not have to stand in the way.It was founded in 2015 and headquartered in Pittsburgh,Pennsylvania.
EnCharge AI — AI Compute from the Edge-to-Cloud for Every Business. Transformative technology for AI computation, breaking records in efficiency and sustainability to enable state-of-the-art models uninhibited by power, space, and cost constraints.
AM Batteries — AM Batteries manufactures Li-ion batteries using solvent-free electrode manufacturing technology. The company was founded in 2016 and is headquartered in Chelmsford, Massachusetts.

Eisai is a pharmaceutical company that researches and delivers medicines for patients.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series C, Funding Round
Japan, United States, China

Portfolio highlights

Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
Ractigen Therapeutics — Early-stage pharma company creating first-in-class therapies boosting expression of therapeutic genes in diseased cells using saRNA.
LIFENET INSURANCE COMPANY — LIFENET INSURANCE COMPANY offers a range of insurance underwriting and asset management solutions. Its insurance products include death, medical, and disability insurance. The company also provides health counselling services. LIFENET INSURANCE COMPANY was founded in October 2006.

SK Securities is a South Korea-based financial service provider that specializes in the securities market. It primarily engaged in securities brokerage, dealing and underwriting businesses, covering stocks, futures, options, government bonds, corporate bonds, foreign exchanges, and financial derivative products. The company also involves in theinvestment banking business, which provides acquisition, project financing services, and wealth management services.SK Securities was founded in 1955.

Investment focus

Apps, Marketing, Financial Services
Series A, Series B, Funding Round
South Korea, United States, Singapore

Portfolio highlights

Rovigos — Rovigos analyzes data from your whole business to help you make better forecasts and choices.
Easy Charger — Easy Charger provides EV infrastructure, electric two-wheeled vehicle battery station, solar power, and platform development services.
Travel Wallet — Travel Wallet is a foreign currency payment service that uses the Travel Wallet application. The travel Pay card is free of charge for overseas payments. The payments are overseas direct purchases and overseas payments without commission. The license for small overseas remittance businesses and electronic financial businesses by meeting variouscomputer facilities and all requirements. The platform agreement with banks.

M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.

Investment focus

Health Care, Food and Beverage, Software
Funding Round, Seed, Series A
France, United States, Canada

Portfolio highlights

Ellona — Ellona offers advanced solutions for odor control and air quality monitoring, providing customized industrial applications. Discover our innovative products and services.
Olino — Olino is the insurance for tomorrow's SME. A digital service, a turnkey solution tailored to VSBs and SMEs, meeting all insurance needs.
Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.

Temasek is a global investment company headquartered in Singapore with a multinational staff of over 900 people. Our portfolio is valued at S$403 billion.

Investment focus

Biotechnology, Health Care, Software
Series B, Series C, Series D
United States, China, India

Portfolio highlights

Yolk.fm — Yolk.fm is a social platform that allows users to chat rather than send text messages.
ShareChat — ShareChat is India's own social network in 14 Indian languages Install ShareChat from Google Play Store for FREE!
Antora Energy — Antora converts low-cost, intermittent renewable electricity into a reliable, on-demand source of zero-emissions industrial heat and power.

Altara Ventures aims to invest in the fintech, consumer, enterprise software, logistics, healthcare and edutech verticals.

Investment focus

Health Care, Financial Services, Finance
Series A, Seed, Series B
Indonesia, Singapore, India

Portfolio highlights

PolicyStreet — PolicyStreet is a regional full-stack InsurTech company. We customise insurance solutions for businesses and consumers.
Kita Agritech — KITA is a unique eCommerce platform that provides wholesale savings and at the same time, success to grocers, retailers, coops and online sellers by providing more affordable access to essential products without having the shell out big capital.
Klinik Pintar — Klinik Pintar membantu pasien mendapatkan layanan kesehatan primer terbaik di klinik, rumah, dan kantor.

Hana Financial Investment Company Limited offers brokerage, securities dealing, underwriting, mutual funds, and online trading services

Investment focus

Information Technology, Biotechnology, Health Care
Series A, Series B, Seed
South Korea, Singapore, India

Portfolio highlights

Trustay — Trustay is a real estate asset management company.
AIZEN Global — AIZEN is redesigning Digital Banking with CreditConnect, powered by our proprietary ABACUS AutoML platform specialized in the financial services industry. CreditConnect is an AI lending platform designed to bridge the gap between banks and data economy platforms, and automate key decision-making processes in accordance with the credit cycle. Thecompany has secured Series B round funding from a state-led fintech innovation fund (K-Growth) led by major Korean banks to roll out CreditConnect in Southeast Asia.We are also leading the digital transformation in the financial services industry using proprietary AutoML platform ABACUS, with successful use cases in underwriting, fraud detection, product development, claim analysis, and more.
Kuntian New Energy — Hebei Kuntian New Energy is a producer of anode materials for lithium-ion batteries.

Openspace Ventures is a leading venture capital firm finding and backing Southeast Asian companies creating a transformative impact where tech meets life.

Investment focus

E-Commerce, Financial Services, Information Technology
Series A, Series B, Seed
Singapore, Indonesia, Philippines

Portfolio highlights

Halodoc — Halodoc merupakan aplikasi kesehatan yang memberikan solusi kesehatan lengkap dan terpercaya untuk memenuhi kebutuhan kesehatan kamu dan keluarga.
Thryve.Earth — Thryve Earth is a platform that unites multiple stakeholders to nature-based carbon projects in a scalable manner.
AMP — We make life simpler for merchants navigating the exponential growth of eCommerce with our suite of powerful software, global community, and educational resources.

Seeds Capital is an investment arm of Enterprise Singapore that co-invests with independent investors in innovative startups. The firm was founded in 1992 and is headquartered in Central Region, Singapore.

Investment focus

Software, Health Care, Biotechnology
Seed, Series A, Funding Round
Singapore, United States, Hong Kong

Portfolio highlights

GDMC — GDMC supports emergent growth companies and innovators in accelerating their genetic medicines to the clinic. We support the manufacturing of Viral Vectors, mRNA and plasmid DNA.
Pyxis — First of its kind electric harbour crafts. 100% electric. Zero emissions.
Prefer — delicious. affordable. sustainable. bean-free coffee.

kt investment is a new technology business finance company established in 2015. It is an investment company that represents KT Group .kt investment seeks to contribute to social contribution and maximize investment return through win-win cooperation with promising SMEs and venture companies .kt investment seeks to achieve long-term returns bylooking at the market from a global perspective and looking for value investment opportunities in the long term.

Investment focus

Artificial Intelligence, Software, Information Technology
Series A, Series B, Seed
South Korea, United States, Singapore

Portfolio highlights

Medipal — Medipal provides personal health for a health consultation. It provides subscription-based personal nurse service for patients.
cafe nono — Gathering together for quality discussions. Making your stories stand out. Join the community here and now!
Rebellions.ai — AI chip architects are often inattentive to advanced deep learning features and requirements because they believe software stacks between their silicon and algorithms can provide effective abstract layers. We disagree. We do not think such naively designed chips can efficiently utilize expensive custom silicon resources. The more native hardwaresupports are enabled, the higher performance is achieved.Rebellions Inc is building genuine AI accelerators by bi-directionally bridging the gap between underlying silicon architectures and deep learning algorithms. We push algorithm boundaries to better exploit silicon budgets, while re-architecting AI processors to incorporate sophisticated deep learning features through silicon-dedicated DL kernels.Our goal is to deliver a domain-specific AI processor along with its optimized software. This approach, together with our unique decentralized programming model, will enable customers to arm with the most powerful yet energy-efficient AI hardware as well as seamless integration.

K3 Ventures provides venture capital for technology startups in various sectors such as finance, education, healthcare, food and agriculture and others. The firm is headed by Kuok Meng Xiong.

Investment focus

Financial Services, FinTech, Software
Series A, Seed, Funding Round
Singapore, United States, Indonesia

Portfolio highlights

WIZ.AI — WIZ.AI Talkbot is a leading Generative AI-powered omnichannel customer engagement solution for enterprises to propel business growth.
Abound — Fintern is a lending startup looking to offer an AI-driven alternative to costly payday loans. It aims to expand access to low-cost personal credit by using the UK’s new Open Banking standard to analyze consumers’ historical bank statement data. Open Banking data allows us to build a granular view of customers’ financial circumstances, properlyunderstand their affordability, and place less reliance on credit reference agency scores.The company was founded in 2020 and is based in London, United Kingdom.
Sending Network — A super-app that combines chat, socializing, and trade, giving you complete control over your social data, while you build communities and share ideas, seamlessly.

Amgen Ventures is a venture capital investment arm of Amgen Inc. specializing in investments in early and later stage companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, andcardiovascular therapeutics. In oncology and hematology it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care including mucositis and cachexia. In nephrology the firm focuses on renal failure and hyperparathyroidism. For inflammation the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in San Francisco, California with additional offices in Seattle, Washington; Thousand Oaks, California; and Cambridge, Massachusetts.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, United Kingdom, Canada

Portfolio highlights

Inversago Pharma — Inversago Pharma is a preclinical-stage, biotech company specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting, CB1 inverse agonists.
Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
Feldan Therapeutics — Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of theunique characteristics of the Shuttle.

Nestlé manufactures and sells food and beverage for several countries. It has generated more than CHF 90 billion in annual revenue. Its diverse product portfolio includes brands such as Nestlé, Nescafé, Perrier, Pure Life, and Purina. Nestlé also owns just over 23% of French cosmetics firm L'Oréal. It has a vast portfolio of global products,with 34 brands each achieving more than CHF 1 billion in sales annually and a geographic presence that spans 189 countries.

Investment focus

Food and Beverage, Health Care, Therapeutics
Private Equity, Grant, Funding Round
United States, United Kingdom, Egypt

Portfolio highlights

GuateValley — GuateValley interconnects local guides with travelers to live experiences in little-known destinations.
Sundial Foods — Sundial Foods utilizes a macro and microstructural engineering approach to create plant-based meat alternatives for conscious consumers.The company is passionate about making the affordable, accessible, and nutritional value of plant-based meats, made from ingredients that customers know and created using simple processes.It is headquartered inBerkeley, California in 2019.
Origin Materials — Origin is a new kind of chemical company, focused on the future of materials science.

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, Ireland, Singapore

Portfolio highlights

Nimbus Therapeutics — Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinicaldevelopment. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
Relievant Medsystems — Relievant's mission is to provide patients with low risk therapy that can alleviate their back pain.
Tagworks Pharmaceuticals — As pioneers of Click-to-Release technology, we are revolutionizing cancer treatment using in vivo click chemistry to increase the therapeutic window of powerful cancer therapies.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate